Curology, founded in 2014 and headquartered in the United States, focuses on providing personalized prescription medications for acne and anti-aging solutions. The company's commitment to accessibility and affordability in skincare has attracted notable Venture Round investment at 01 April 2021 from ACME Capital, Advance Venture Partners, and IVP. Curology's dedication to inspiring confidence beyond skin deep is evident in its comprehensive range of dermatologist-designed products and its mission to make professional acne care accessible to millions. The company's unique approach, highlighted by 1:1 interactions with dermatology providers, aims to transform skin health and enhance lives. With a focus on consumer goods, healthcare, and wellness beauty, Curology presents an innovative and promising investment opportunity in the skincare industry. For those interested in joining this mission, Curology is actively hiring, offering an opportunity to be part of their transformative journey.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | Unknown | 3 | 01 Apr 2021 | |
Series D | Unknown | 4 | 26 Nov 2019 | |
Venture Round | Unknown | 1 | TriplePoint Ventures | 01 Jan 2017 |
Series B | $15.00M | 5 | Shervin Pishevar, Forerunner | 25 Aug 2016 |
Series A | $4.15M | 3 | Shervin Pishevar, Forerunner | 30 Dec 2014 |
No recent news or press coverage available for Curology.